284 related articles for article (PubMed ID: 26252568)
1. Risk of Disease After Isoniazid Preventive Therapy for Mycobacterium tuberculosis Exposure in Young HIV-uninfected Children.
Luabeya KK; Tameris MD; Geldenhuys HD; Mulenga H; Van Schalkwyk A; Hughes EJ; Toefey A; Scriba TJ; Hussey G; Mahomed H; McShane H; Landry B; Hanekom WA; Hatherill M
Pediatr Infect Dis J; 2015 Nov; 34(11):1218-22. PubMed ID: 26252568
[TBL] [Abstract][Full Text] [Related]
2. Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB gold in-tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study.
Johnson JL; Geldenhuys H; Thiel BA; Toefy A; Suliman S; Pienaar B; Chheng P; Scriba T; Boom WH; Hanekom W; Hatherill M
Chest; 2014 Mar; 145(3):612-7. PubMed ID: 24135768
[TBL] [Abstract][Full Text] [Related]
3. The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study.
Hermans SM; Grant AD; Chihota V; Lewis JJ; Vynnycky E; Churchyard GJ; Fielding KL
BMC Med; 2016 Mar; 14():45. PubMed ID: 27004413
[TBL] [Abstract][Full Text] [Related]
4. Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data.
Otero L; Battaglioli T; Ríos J; De la Torre Z; Trocones N; Ordoñez C; Seas C; Van der Stuyft P
Trop Med Int Health; 2020 Mar; 25(3):346-356. PubMed ID: 31758837
[TBL] [Abstract][Full Text] [Related]
5. QuantiFERON-TB Gold In-Tube Test for Tuberculosis Prevention in HIV-Infected Patients.
Khawcharoenporn T; Phetsuksiri B; Rudeeaneksin J; Srisungngam S; Apisarnthanarak A
Jpn J Infect Dis; 2017 Sep; 70(5):502-506. PubMed ID: 28367883
[TBL] [Abstract][Full Text] [Related]
6. Infant TB Infection Prevention Study (iTIPS): a randomised trial protocol evaluating isoniazid to prevent
LaCourse SM; Richardson BA; Kinuthia J; Warr AJ; Maleche-Obimbo E; Matemo D; Cranmer LM; Escudero JN; Hawn TR; John-Stewart GC
BMJ Open; 2020 Jan; 10(1):e034308. PubMed ID: 31969368
[TBL] [Abstract][Full Text] [Related]
7. A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.
Sensalire S; Karungi Karamagi Nkolo E; Nabwire J; Lawino A; Kiragga D; Muhire M; Kadama H; Katureebe C; Namuwenge P; Musinguzi J; Calnan J; Seyoum D
AIDS Res Ther; 2020 May; 17(1):28. PubMed ID: 32460788
[TBL] [Abstract][Full Text] [Related]
8. Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South Africa.
Page-Shipp L; Lewis JJ; Velen K; Senoge S; Zishiri E; Popane F; Chihota VN; Clark D; Churchyard GJ; Charalambous S
PLoS One; 2018; 13(3):e0192089. PubMed ID: 29499060
[TBL] [Abstract][Full Text] [Related]
9. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study.
Sabasaba A; Mwambi H; Somi G; Ramadhani A; Mahande MJ
BMC Infect Dis; 2019 Jan; 19(1):62. PubMed ID: 30654753
[TBL] [Abstract][Full Text] [Related]
10. The Magnitude of Interferon Gamma Release Assay Responses in Children With Household Tuberculosis Contact Is Associated With Tuberculosis Exposure and Disease Status.
Ronge L; Sloot R; Du Preez K; Kay AW; Kirchner HL; Grewal HMS; Mandalakas AM; Hesseling AC
Pediatr Infect Dis J; 2021 Aug; 40(8):763-770. PubMed ID: 34050092
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis.
Geremew D; Endalamaw A; Negash M; Eshetie S; Tessema B
BMC Infect Dis; 2019 May; 19(1):405. PubMed ID: 31077133
[TBL] [Abstract][Full Text] [Related]
12. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.
Assebe LF; Reda HL; Wubeneh AD; Lerebo WT; Lambert SM
BMC Public Health; 2015 Apr; 15():346. PubMed ID: 25886730
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal analysis of QuantiFERON-TB Gold In-Tube in children with adult household tuberculosis contact in South Africa: a prospective cohort study.
Shah M; Kasambira TS; Adrian PV; Madhi SA; Martinson NA; Dorman SE
PLoS One; 2011; 6(10):e26787. PubMed ID: 22066009
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis preventive therapy: an underutilised strategy to reduce individual risk of TB and contribute to TB control.
Churchyard GJ; Chaisson RE; Maartens G; Getahun H
S Afr Med J; 2014 Apr; 104(5):339-43. PubMed ID: 25212199
[TBL] [Abstract][Full Text] [Related]
15. Impact of Baseline Tuberculin Skin Test and Isoniazid Chemoprophylaxis on Subsequent Quantiferon-TB Gold In-Tube Performance in Young Children Assessed After Tuberculosis Contact in Catalonia.
Velasco-Arnaiz E; Soriano-Arandes A; Espiau M; Altet N; Fortuny C; Monsonís M; Tebruegge M; Noguera-Julian A
Pediatr Infect Dis J; 2020 Feb; 39(2):e22-e25. PubMed ID: 31738322
[TBL] [Abstract][Full Text] [Related]
16. Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study.
Biraro IA; Egesa M; Kimuda S; Smith SG; Toulza F; Levin J; Joloba M; Katamba A; Cose S; Dockrell HM; Elliott AM
BMC Infect Dis; 2015 Oct; 15():438. PubMed ID: 26493989
[TBL] [Abstract][Full Text] [Related]
17. Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania.
Maokola WM; Ngowi BJ; Mahande MJ; Todd J; Robert M; Msuya SE
PLoS One; 2021; 16(7):e0254082. PubMed ID: 34255776
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
Semu M; Fenta TG; Medhin G; Assefa D
BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
[TBL] [Abstract][Full Text] [Related]
19. Implementation and Operational Research: Implementation of the WHO 2011 Recommendations for Isoniazid Preventive Therapy (IPT) in Children Living With HIV/AIDS: A Ugandan Experience.
Costenaro P; Massavon W; Lundin R; Nabachwa SM; Fregonese F; Morelli E; Alowo A; Nannyonga Musoke M; Namisi CP; Kizito S; Bilardi D; Mazza A; Cotton MF; Giaquinto C; Penazzato M
J Acquir Immune Defic Syndr; 2016 Jan; 71(1):e1-8. PubMed ID: 26761275
[TBL] [Abstract][Full Text] [Related]
20. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.
Hunter OF; Kyesi F; Ahluwalia AK; Daffé ZN; Munseri P; von Reyn CF; Adams LV
BMC Infect Dis; 2020 Oct; 20(1):738. PubMed ID: 33028260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]